Post by Biogen

1,300,750 followers

Today, together with Eisai, we announced that the U.S. Food and Drug Administration (FDA) has approved a new delivery option for people living with early Alzheimer’s disease.     This milestone reflects our commitment to addressing the evolving needs of the Alzheimer’s disease community. Learn more: https://lnkd.in/eXHqiHzz   #News

Post content

Video Content